OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Sidney Strickland

5 Projects | 1 Researchers | $976,480 Invested

2019

The Rockefeller University

Sidney Strickland, PhD

ELISA assay for cleaved high molecular weight kininogen (HKc) as a diagnostic tool for Alzheimer’s disease (AD)

  • Funding Amount: $320,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Vascular
  • Status: Closed

2010

The Rockefeller University

Sidney Strickland, PhD

Interaction between Abeta and Fibrinogen: A New Therapeutic Target for Alzheimer's Disease

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2008

The Rockefeller University

Sidney Strickland, PhD

Interaction between Abeta and Fibrinogen: A New Therapeutic Target for Alzheimer's Disease

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2006

The Rockefeller University

Sidney Strickland, PhD

Screening for PAI-1 inhibitors to increase plasmin AlphaBeta- degrading activity

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2001

The Rockefeller University

Sidney Strickland, PhD

Analysis of the Role to tPA and Plasmino(gen) in Alzheimer's Disease

  • Funding Amount: $256,480
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed